What's New

CE Education
Relapse After Transplant: Next Steps for Patients with Hodgkin Lymphoma
Alison Moskowitz, MD
CE Education
A Practical Guide to PET-Adapted Therapy for Hodgkin Lymphoma
Peter Johnson, MD
CE Education
2016 EHA Annual Meeting Highlights in HL
Peter Borchmann, MD; Paul Bröckelmann, MD; Astrid Pavlovsky, MD; and Anas Younes, MD
CE Education
First-line Treatment of HL: Differential Treatment Strategies in Newly Diagnosed Patients with Early- versus Advanced-Stage Disease
Andrew M. Evens, DO, MSc, FACP
Case Discussion
Relapse After Transplant: A Case Study in Navigating Hodgkin Lymphoma Treatment Pathways
Alison J. Moskowitz, MD
FAQ Library
What treatment options exist for HL patients at risk for relapse or disease progression after transplant?
How do you identify HL patients at risk for relapse or disease progression after transplant?
Paul Bröckelmann, MD
FAQ Library
What new/emerging treatments for relapsed/refractory HL are most likely to improve patient outcomes?
Robert W. Chen, MD
FAQ Library
What are the roles of immunohistochemistry studies versus flow cytometry results in diagnosing HL?
Andrew M. Evens, DO, MSc, FACP
FAQ Library
What treatment approaches may increase chances for a higher cure rate in patients with R/R HL?
Robert W. Chen, MD
FAQ Library
When is it appropriate and/or necessary to utilize mRNA testing in the diagnosis and staging of HL?
Which factors are more important when developing treatment plans for the newly diagnosed HL patient?
Andrew M. Evens, DO, MSc, FACP

Managing HL would like to recognize and thank Takeda Oncology for its educational support of ManagingHodgkinLymphoma.com

©2016 MediCom Worldwide, Inc. All rights reserved